Trondheim

Norway

183 total trials 96 recruiting

Filter these 183 trials by phase, condition, sponsor and more.

Open in Search →

Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended

2022-500363-12-00 4 2022-08-24 SARS CoV-2 (COVID-19)
Efficacy and safety of UV1 vaccination +/- standard of care as first line treatment of patients with non-small cell lung cancer Ended

2022-502437-25-00 4 2022-08-15 advanced or metastatic non-small cell lung cancer
Cohort study of human mpox virus disease Ended

2022-501132-42-00 6 2022-08-02 Monkeypox virus disease
A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose comb … Ended

2024-518527-29-00 4 2022-05-24 Polycystic ovary syndrome (PCOS)
Clinical trial of MK-4280A for colorectal cancer that has spread after previous treatment Ended

2024-511043-25-00 5 2021-11-30 Colorectal Cancer
PARASTOP - Paracetamol with Strong Opioids Ended

2024-515012-53-00 5 2021-10-20 Metastatic cancer disease
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 5 2021-06-03 SARS-CoV II infection (Coronavirus disease)
The My-JIA trial Ended

2023-510118-21-00 6 2020-12-01 Juvenile Idiopathic Arthritis
Treatment with Acalabrutinib in patients with chronic lymphocytic leukemia Ended

2023-507669-24-00 5 2019-11-05 Chronic lymphocytic leukemia
The MiBlock study Ended

2024-515165-34-00 5 2019-10-01 Chronic migraine
First line treatment with osimertinib in non-small cell lung cancer, coupled with studies on biological samples. Ended

2024-513881-20-00 4 2018-11-19 EGFR-mutated non-small cell lung cancer
Intermittent ibrutinib in chronic lymphocytic leukemia Ended

2023-508638-32-00 3 2018-04-06 Chronic lymphocytic leukemia
A prospective, multicenter, phase-II trial of ibrutinib plus venetoclax in physically fit patients with creatinine clearance ≥ 30 ml/min who … Ended

2023-510557-42-00 4 2017-07-10 chronic lymphocytic leukemia
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized Europea … Ended

2024-511235-10-00 5 2016-07-25 Generalized mantle cell Lymphoma
HD21 Ended

2024-518022-33-00 5 2016-07-15 Advanced Stage of Hodgkin Lymphoma

Showing 169–183 of 183 trials